Cortizone-10 launches hydrocortisone-based itch relief spray

The over-the-counter treatment contains 1% hydrocortisone - the maximum strength permitted without a prescription in the United States -and is formulated with aloe to help soothe the skin.
The product is dispensed as a fine, no-touch aerosol mist, allowing application without direct contact with the skin.
The spray format also offers ease of use on hard-to-reach areas of the body, a key functional advantage over traditional creams.
The new format is expected to appeal to users dealing with common skin irritations such as insect bites, eczema, or allergic reactions.
Cortizone-10, a brand owned by Sanofi Consumer Healthcare, remains one of the most widely recognised names in topical corticosteroid treatments in North America.
To coincide with the launch, Cortizone-10 has partnered with content creator Dylan Efron and the US-based National Park Foundation to promote the product during peak outdoor season.
